278 related articles for article (PubMed ID: 18701085)
21. Status of IL-4 and IL-10 driven markers in experimental models of Visceral Leishmaniasis.
Moulik S; Karmakar J; Joshi S; Dube A; Mandal C; Chatterjee M
Parasite Immunol; 2021 Jan; 43(1):e12783. PubMed ID: 32734677
[TBL] [Abstract][Full Text] [Related]
22. Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophils.
McFarlane E; Carter KC; McKenzie AN; Kaye PM; Brombacher F; Alexander J
J Infect Dis; 2011 Jul; 204(1):36-43. PubMed ID: 21628656
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro.
Kaye PM; Bancroft GJ
Infect Immun; 1992 Oct; 60(10):4335-42. PubMed ID: 1398944
[TBL] [Abstract][Full Text] [Related]
24. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
Manna PP; Hira SK; Basu A; Bandyopadhyay S
Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
[TBL] [Abstract][Full Text] [Related]
25. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
[TBL] [Abstract][Full Text] [Related]
26. CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice.
Alexander CE; Kaye PM; Engwerda CR
Eur J Immunol; 2001 Apr; 31(4):1199-210. PubMed ID: 11298345
[TBL] [Abstract][Full Text] [Related]
27. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
[TBL] [Abstract][Full Text] [Related]
28. Tissue granuloma structure-function in experimental visceral leishmaniasis.
Murray HW
Int J Exp Pathol; 2001 Oct; 82(5):249-67. PubMed ID: 11703536
[TBL] [Abstract][Full Text] [Related]
29. Differential Induction of SOCS Isoforms by
Chandrakar P; Parmar N; Descoteaux A; Kar S
J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
[TBL] [Abstract][Full Text] [Related]
30. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology.
Smelt SC; Cotterell SE; Engwerda CR; Kaye PM
J Immunol; 2000 Apr; 164(7):3681-8. PubMed ID: 10725726
[TBL] [Abstract][Full Text] [Related]
31. Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity.
Murray HW; Squires KE; Miralles CD; Stoeckle MY; Granger AM; Granelli-Piperno A; Bogdan C
J Immunol; 1992 Mar; 148(6):1858-63. PubMed ID: 1541824
[TBL] [Abstract][Full Text] [Related]
32. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
Volpedo G; Pacheco-Fernandez T; Bhattacharya P; Oljuskin T; Dey R; Gannavaram S; Satoskar AR; Nakhasi HL
Front Immunol; 2021; 12():748325. PubMed ID: 34712235
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
34. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
[TBL] [Abstract][Full Text] [Related]
35. Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4
Kumari S; Shivam P; Kumar S; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Cytokine; 2018 Oct; 110():306-315. PubMed ID: 29807685
[TBL] [Abstract][Full Text] [Related]
36. CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major.
Ishikawa H; Hisaeda H; Taniguchi M; Nakayama T; Sakai T; Maekawa Y; Nakano Y; Zhang M; Zhang T; Nishitani M; Takashima M; Himeno K
Int Immunol; 2000 Sep; 12(9):1267-74. PubMed ID: 10967021
[TBL] [Abstract][Full Text] [Related]
37. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
[TBL] [Abstract][Full Text] [Related]
38. The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis.
Mesquita I; Ferreira C; Barbosa AM; Ferreira CM; Moreira D; Carvalho A; Cunha C; Rodrigues F; Dinis-Oliveira RJ; Estaquier J; Castro AG; Torrado E; Silvestre R
Cytokine; 2018 Dec; 112():16-20. PubMed ID: 30017388
[TBL] [Abstract][Full Text] [Related]
39. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
[TBL] [Abstract][Full Text] [Related]
40. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
